Kalaris Therapeutics (KLRS) Other Non-Current Assets (2021 - 2026)
Kalaris Therapeutics (KLRS) reported Other Non-Current Assets of $1.73 million for Q2 2026, up 150.2% from $691,000 a year earlier but down 1.4% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Other Non-Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Kalaris Therapeutics posted Other Non-Current Assets of $953,000, down 69.7% from FY2024.
- Other Non-Current Assets has a four-year compound annual growth rate of -3.6% (FY2021 to FY2025).
- By year, Other Non-Current Assets came in at $3.15 million in FY2024 (+269.2%), $852,000 in FY2023 (unchanged), $852,000 in FY2022 (-22.7%) and $1.1 million in FY2021.
- Five-year quarterly Other Non-Current Assets spans a low of $500,000 in Q1 2025 and a high of $3.15 million in Q4 2024.
- Year over year, Other Non-Current Assets gained in four of the last six quarters, with growth averaging 102.6%.
- The high point for year-over-year Other Non-Current Assets in five years was Q4 2024 (growth of 269.2%); the low point was Q4 2025 (a decline of 69.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.75 million (Q1 2026), $953,000 (Q4 2025) and $976,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Kalaris Therapeutics | 44.52 Mn | -38.38 Mn | - | 2.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.48 Mn |
| Jun 30, 2026 | 2.23 Mn |
| Mar 31, 2026 | 2.25 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | 910,000.00 |
| Dec 31, 2024 | 3.56 Mn |
| Jun 30, 2024 | 554,000.00 |
| Mar 31, 2024 | 554,000.00 |
| Dec 31, 2023 | 974,000.00 |
| Sep 30, 2023 | 2.28 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 1.59 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 1.83 Mn |
| Dec 31, 2021 | 1.95 Mn |
| Sep 30, 2021 | 2.06 Mn |
API Access
Kalaris Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();